Skip to main content
Livermore
Livermore
ZHEN

Captrust Financial Advisors

SEC CIK
0001512024
Latest filing
Aug 13, 2026

GSK holding history

GSK plc in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
65,208
Value
$3.42M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Captrust Financial Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202665,208$3.42M<0.1%+3,372+5.5%AddedHolders
Q1 202661,836$3.41M<0.1%−10,203−14.2%ReducedHolders
Q4 202572,039$3.53M<0.1%−6,605−8.4%ReducedHolders
Q3 202578,644$3.39M<0.1%−6,436−7.6%ReducedHolders
Q2 202585,080$3.27M<0.1%+8,432+11.0%AddedHolders
Q1 202576,648$2.97M<0.1%−3,874−4.8%ReducedHolders
Q4 202480,522$2.72M<0.1%−1,138,322−93.4%ReducedHolders
Q3 20241,218,844$49.8M0.1%−8,239−0.7%ReducedHolders
Q2 20241,227,083$47.2M0.2%−213,727−14.8%ReducedHolders
Q1 20241,440,810$52.8M0.2%+226,995+18.7%AddedHolders
Q4 20231,213,815$45.0M0.2%−38,321−3.1%ReducedHolders
Q3 20231,252,136$45.4M0.2%−7,151−0.6%ReducedHolders
Q2 20231,259,287$44.9M0.2%−2,195−0.2%ReducedHolders
Q1 20231,261,482$44.9M0.2%+73,929+6.2%AddedHolders
Q4 20221,187,553$41.7M0.2%−95,107−7.4%ReducedHolders
Q3 20221,282,660$37.7M0.2%+251,352+24.4%AddedHolders
Q2 20221,031,308$45.2M0.3%+93,154+9.9%AddedHolders
Q1 2022938,154$41.4M0.3%+29,228+3.2%AddedHolders
Q4 2021908,926$40.5M0.3%−4,059−0.4%ReducedHolders
Q3 2021912,985$35.4M0.3%+140,056+18.1%AddedHolders
Q2 2021772,929$31.1M0.3%+165,329+27.2%AddedHolders
Q1 2021607,600$22.1M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.